LRD

LRD, or Leukemia Research Doctors, is a non-profit organization dedicated to funding cutting-edge leukemia research. Founded in 1991, LRD has been instrumental in advancing the understanding and treatment of leukemia, a group of cancers that begin in the blood and bone marrow. The organization's mission is to accelerate the development of new therapies and improve the lives of patients diagnosed with leukemia.

LRD operates through a unique model that combines the expertise of leading leukemia researchers with the financial support of the public. The organization's board of directors is composed of prominent scientists and clinicians who provide scientific guidance and oversight. LRD's funding comes from individual donors, foundations, and corporate sponsors, ensuring that the research it supports is driven by the needs of the leukemia community.

One of LRD's key initiatives is the Leukemia & Lymphoma Society (LLS) Scholar Award Program, which provides funding for early-career researchers to pursue innovative leukemia research. LRD also supports clinical trials and collaborative research projects, fostering a multidisciplinary approach to leukemia research. The organization's efforts have led to significant advancements in the field, including the development of new drug therapies and improved diagnostic tools.

LRD is committed to transparency and accountability in its operations. The organization publishes annual reports detailing its activities, financials, and the impact of its research funding. LRD also maintains a strong commitment to patient advocacy, working to raise awareness about leukemia and support patients and their families throughout the treatment process. Through its dedication to research and advocacy, LRD continues to make a meaningful difference in the fight against leukemia.